scholarly journals Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression

2016 ◽  
Vol 18 (1) ◽  
pp. 7 ◽  
Author(s):  
Anne von Mässenhausen ◽  
Johannes Brägelmann ◽  
Hannah Billig ◽  
Britta Thewes ◽  
Angela Queisser ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Tyrosine Kinase ◽  
Head And Neck ◽  
Cancer Progression ◽  
Neck Cancer ◽  
Receptor Tyrosine Kinase

S115 The Receptor Tyrosine Kinase c-MET Is Mutated in Head and Neck Cancer and Is a Promising Novel Target

2006 ◽  
Vol 132 (8) ◽  
pp. 864
Author(s):  
T. Y. Seiwert ◽  
A. J. Klein-Szanto ◽  
R. Jagadeeswaran ◽  
M. Tretiakova ◽  
L. Martin ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Tyrosine Kinase ◽  
Head And Neck ◽  
Neck Cancer ◽  
Receptor Tyrosine Kinase ◽  
Kinase C ◽  
Novel Target

The Receptor Tyrosine Kinase c-MET as a Novel Therapeutic Target in Head and Neck Cancer

2007 ◽  
Vol 69 (2) ◽  
pp. S137
Author(s):  
T. Seiwert ◽  
V. Janamanchi ◽  
A. Klein-Szanto ◽  
R. Jagadeeswaran ◽  
L. Martin ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Tyrosine Kinase ◽  
Head And Neck ◽  
Neck Cancer ◽  
Receptor Tyrosine Kinase ◽  
Therapeutic Target ◽  
Kinase C ◽  
Novel Therapeutic

scholarly journals The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors

Cancers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2280
Author(s):  
Melissa B. Aldrich ◽  
John C. Rasmussen ◽  
Caroline E. Fife ◽  
Simona F. Shaitelman ◽  
Eva M. Sevick-Muraca
Keyword(s):  
Breast Cancer ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Cancer Progression ◽  
Neck Cancer ◽  
Cancer Metastasis ◽  
Near Infrared ◽  
Critical Role ◽  
Lymphatic Function

Breast-cancer-acquired lymphedema is routinely diagnosed from the appearance of irreversible swelling that occurs as a result of lymphatic dysfunction. Yet in head and neck cancer survivors, lymphatic dysfunction may not always result in clinically overt swelling, but instead contribute to debilitating functional outcomes. In this review, we describe how cancer metastasis, lymph node dissection, and radiation therapy alter lymphatic function, as visualized by near-infrared fluorescence lymphatic imaging. Using custom gallium arsenide (GaAs)-intensified systems capable of detecting trace amounts of indocyanine green administered repeatedly as lymphatic contrast for longitudinal clinical imaging, we show that lymphatic dysfunction occurs with cancer progression and treatment and is an early, sub-clinical indicator of cancer-acquired lymphedema. We show that early treatment of lymphedema can restore lymphatic function in breast cancer and head and neck cancer patients and survivors. The compilation of these studies provides insights to the critical role that the lymphatics and the immune system play in the etiology of lymphedema and associated co-morbidities.

Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer

Oral Oncology ◽  
2020 ◽  
Vol 101 ◽  
pp. 104529 ◽  
Author(s):  
Morgan Black ◽  
Farhad Ghasemi ◽  
Ren X. Sun ◽  
William Stecho ◽  
Alessandro Datti ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Human Papillomavirus ◽  
Tyrosine Kinase ◽  
Head And Neck ◽  
Neck Cancer ◽  
Spleen Tyrosine Kinase ◽  
Kinase Expression

Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression

2017 ◽  
Vol 125 (4) ◽  
pp. 247-257 ◽  
Author(s):  
E. E. Hinsley ◽  
C. E. de Oliveira ◽  
S. Hunt ◽  
R. D. Coletta ◽  
D. W. Lambert
Keyword(s):  
Head And Neck Cancer ◽  
Angiotensin Ii ◽  
Head And Neck ◽  
Cancer Progression ◽  
Neck Cancer

scholarly journals Serumal and Salivary 25(OH)D and 1,25(OH)D Levels of Head and Neck Cancer Patients

2021 ◽  
Vol 13 (4) ◽  
pp. 438-43
Author(s):  
Dina Keumala Sari ◽  
Liza Meutia Sari ◽  
Lidya Imelda Laksmi ◽  
Farhat Farhat ◽  
Elvita Rahmi Daulay ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Progression ◽  
Neck Cancer ◽  
Medical Records ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Exclusion Criteria ◽  
Dihydroxyvitamin D ◽  
Saliva Collection

BACKGROUND: Saliva has been suggested as a substitute of serum for the detection of 25 Dihydroxyvitamin D (25(OH)D) in healthy people. However, investigation of salivary 1,25(OH)D has not been clearly reported. Vitamin plays important roles in inhibiting cancer progression. Current study was conducted to investigate serumal and salivary 25(OH)D) and 1,25(OH)D levels of healthy and head and neck cancer (HNC) subjects.METHODS: Research were conducted at Haji Adam Malik Hospital, Medan, Indonesia. Forty HNC and 40 healthy subjects were recruited and selected based on inclusion and exclusion criteria. Medical records were documented, followed by anthropometric evaluation and serum and saliva collection. Laboratory investigation for 25(OH)D and 1,25(OH) was performed using Enzyme-linked immunosorbent assay (ELISA) methods.RESULTS: Significant serumal (p=0.002) and salivary (p=0.016) 25(OH)D mean level differences of HNC and normal groups were obtained. More serumal or salivary 25(OH)D deficient subjects were found in control group than those in HNC group. Meanwhile, serumal and salivary 1,25(OH)D mean levels of HNC group were not significantly different with the ones of control group. There were significant correlations of serumal-salivary 25(OH)D as well as serumal-salivary 1,25(OH)D levels in normal group.CONCLUSION: Serumal and salivary 25(OH)D and 1,25(OH)D levels of HNC group were relatively normal. Salivary 25(OH)D and 1,25(OH)D could be suggested as substitutes for serumal ones.KEYWORDS: vitamin D, 25(OH)D, 1,25(OH)D, head and neck cancer

A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer

2019 ◽  
Vol 98 (5) ◽  
pp. 489-497 ◽  
Author(s):  
P.J. Polverini ◽  
M.W. Lingen
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Progression ◽  
Neck Cancer ◽  
New Technologies ◽  
Treatment Strategies ◽  
Disease Process ◽  
Treatment Protocols ◽  
Multistep Process ◽  
Etiological Agents

Historical records as far back as 3000 BCE show that oral and head and neck cancer was a disease process well known to Egyptian physicians. Luminaries such as Hippocrates, Galen, Pott, and Virchow were instrumental in shaping our understanding of the etiology and pathogenesis of cancer. During the 20th century, evidence-based medicine catalyzed the development of rigorous science-based diagnostic and treatment protocols. The use of surgery, therapeutic radiation, and chemotherapy as single-treatment agents or in combination with one another gradually emerged as the preferred approach to cancer therapy. The recognition of tobacco, alcohol, and human papillomavirus as etiological agents in oral and head and neck cancer prompted the development of new diagnostic aids and treatment strategies to mitigate cancer progression. More in-depth mechanistic insights into the multistep process of oral and head and neck cancer were made possible by the use of the hamster buccal pouch and mouse models. New technologies, such as the sequencing of the human genome, metabolomics, and proteomics, have provided the foundation for what we today call precision medicine. The future success of tailored medical treatment for cancer patients will depend on the discovery of new druggable targets with improved therapeutic efficacy. As the precision and sensitivity of existing tools for prevention and risk assessment improve, greater accuracy will be achieved in predicting health outcomes.

Sign in / Sign up

Export Citation Format

Share Document